{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:34:16Z","timestamp":1780508056277,"version":"3.54.1"},"reference-count":40,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2024.2025.0125","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:04:52Z","timestamp":1749636292000},"source":"Crossref","is-referenced-by-count":2,"title":["The Composite Health Risk Assessment Model (CHARM) Predicted Overall Mortality and Relapse, but not Non-Relapse Mortality, in Adults Following Unrelated Single-Unit Cord Blood Transplantation"],"prefix":"10.4274","author":[{"given":"Seiko","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Monna-oiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Andoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-Specific Comorbidity Index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","unstructured":"1. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-Specific Comorbidity Index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912-2919.","journal-title":"Blood"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","article-title":"A risk score for mortality after allogeneic hematopoietic cell transplantation","volume":"144","author":"Parimon","year":"2006","unstructured":"2. Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med. 2006;144:407-414.","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.bbmt.2015.01.011","article-title":"Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation","volume":"21","author":"BK","year":"2015","unstructured":"3. Au BK, Gooley TA, Armand P, Fang M, Madtes DK, Sorror ML, Boeckh MJ, Gibson CJ, Deeg HJ, Storb R, Appelbaum FR, Chien JW, Martin PJ. Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant. 2015;21:848-854.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","unstructured":"4. Gratwohl A. The EBMT risk score. Bone marrow transplant. 2012;47:749-756.","journal-title":"Bone marrow transplant"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41409-020-01032-9","article-title":"Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia","volume":"56","author":"Yanada","year":"2021","unstructured":"5. Yanada M, Konuma T, Mizuno S, Saburi M, Shinohara A, Tanaka M, Marumo A, Sawa M, Uchida N, Ozawa Y, Onizuka M, Yoshioka S, Nakamae H, Kondo T, Kimura T, Kanda J, Fukuda T, Atsuta Y, Nakasone H, Yano S. Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia. Bone Marrow Transplant. 2021;56:387-394.","journal-title":"Bone Marrow Transplant"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41375-022-01574-5","article-title":"Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"36","author":"Zarling","year":"2022","unstructured":"6. Zarling LC, Othus M, Sandmaier BM, Milano F, Schoch G, Davis C, Bleakley M, Deeg HJ, Appelbaum FR, Storb R, Walter RB. Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Leukemia. 2022;36:1563-1574.","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/bmt.2016.141","article-title":"Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation","volume":"51","author":"Elsawy","year":"2016","unstructured":"7. Elsawy M, Sorror ML. Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2016;51:1283-1300.","journal-title":"Bone Marrow Transplant"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood.2022017999","article-title":"The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigators","volume":"141","author":"Sorror","year":"2023","unstructured":"8. Sorror ML. The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigators. Blood. 2023;141:2173-2186.","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Artz A, Logan BR, Saber W, Geller N, Bellach A, Kou J, Wood W, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Schuler T, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris L, Imus P, Hogan WJ, Nadiminti K, Bhatt VR, Mattila D, Protz B, Devine SM, Horowitz MM, Sorror M. The Composite Health Risk Assessment Model (CHARM) to predict 1-year non-relapse mortality (NRM) among older recipients of allogeneic transplantation: a prospective BMT-CTN study 1704. Blood. 2023;142(Suppl 1):109 (abstract).","DOI":"10.1182\/blood-2023-173855"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1182\/blood-2004-03-1001","article-title":"Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies","volume":"104","author":"Takahashi","year":"2004","unstructured":"10. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, Yamada T, Uchimaru K, Tojo A, Shirafuji N, Kodo H, Tani K, Takahashi T, Yamaguchi T, Asano S. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813-3820.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1182\/blood-2006-04-020172","article-title":"Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen","volume":"109","author":"Takahashi","year":"2007","unstructured":"11. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, Fukuno K, Uchiyama M, Takasugi K, Iseki T, Tojo A, Yamaguchi T, Asano S. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood. 2007;109:1322-1330.","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","unstructured":"12. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE; Center for International Blood and Marrow Transplant Research; Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation); National Cord Blood Program of the New York Blood Center. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11:653-660.","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Shouval R, Fein JA, Labopin M, Kr\u00f6ger N, Duarte RF, Bader P, Chabannon C, Kuball J, Basak GW, Dufour C, Galimard JE, Polge E, Lankester A, Montoto S, Snowden JA, Styczynski J, Yakoub-Agha I, Mohty M, Nagler A. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. Lancet Haematol. 2019;6:e573-e584.","DOI":"10.1016\/S2352-3026(19)30158-9"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ajh.25705","article-title":"Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017","volume":"95","author":"Konuma","year":"2020","unstructured":"14. Konuma T, Kanda J, Inamoto Y, Hayashi H, Kobayashi S, Uchida N, Sugio Y, Tanaka M, Kobayashi H, Kouzai Y, Takahashi S, Eto T, Mukae J, Matsuhashi Y, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Kimura F. Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017. Am J Hematol. 2020;95:343-353.","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.bbmt.2008.06.008","article-title":"Does the hematopoietic cell transplantation Specific Comorbidity Index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants","volume":"14","author":"Majhail","year":"2008","unstructured":"15. Majhail NS, Brunstein CG, McAvoy S, DeFor TE, Al-Hazzouri A, Setubal D, Arora M, Le CT, Wagner JE, Weisdorf DJ. Does the hematopoietic cell transplantation Specific Comorbidity Index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants. Biol Blood Marrow Transplant. 2008;14:985-992.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.bbmt.2018.02.013","article-title":"Promising outcome of umbilical cord blood transplantation in patients with multiple comorbidities","volume":"24","author":"Adachi","year":"2018","unstructured":"16. Adachi Y, Ukai S, Sagou K, Fukushima N, Ozeki K, Kohno A. Promising outcome of umbilical cord blood transplantation in patients with multiple comorbidities. Biol Blood Marrow Transplant. 2018;24:1455-1462.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbmt.2017.01.084","article-title":"Prognostic value of the hematopoietic cell transplantation comorbidity index for patients undergoing reduced-intensity conditioning cord blood transplantation","volume":"23","author":"Salit","year":"2017","unstructured":"17. Salit RB, Oliver DC, Delaney C, Sorror ML, Milano F. Prognostic value of the hematopoietic cell transplantation comorbidity index for patients undergoing reduced-intensity conditioning cord blood transplantation. Biol Blood Marrow Transplant. 2017;23:654-658.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ajh.27174","article-title":"Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: a study on behalf of the Donor\/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy","volume":"99","author":"Konuma","year":"2024","unstructured":"18. Konuma T, Harada K, Shinohara A, Uchida N, Shingai N, Ito A, Ozawa Y, Tanaka M, Sawa M, Onizuka M, Katayama Y, Hiramoto N, Nakano N, Kimura T, Kanda Y, Fukuda T, Atsuta Y, Nakasone H, Kanda J. Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: a study on behalf of the Donor\/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy. Am J Hematol. 2024;99:263-273.","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbmt.2013.12.555","article-title":"Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission","volume":"20","author":"Konuma","year":"2014","unstructured":"19. Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Asano S, Tojo A, Takahashi S. Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission. Biol Blood Marrow Transplant. 2014;20:396-401.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3109\/10428194.2014.949261","article-title":"Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide","volume":"56","author":"Konuma","year":"2015","unstructured":"20. Konuma T, Kato S, Oiwa-Monna M, Tojo A, Takahashi S. Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide. Leuk Lymphoma. 2015;56:1148-1150.","journal-title":"Leuk Lymphoma"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.bbmt.2018.12.004","article-title":"Reduced-toxicity myeloablative conditioning consisting of fludarabine\/busulfan\/low-dose total body irradiation\/granulocyte colony-stimulating factor-combined cytarabine in single cord blood transplantation for elderly patients with nonremission myeloid malignancies","volume":"25","author":"Konuma","year":"2019","unstructured":"21. Konuma T, Kato S, Isobe M, Mizusawa M, Oiwa-Monna M, Takahashi S, Tojo A. Reduced-toxicity myeloablative conditioning consisting of fludarabine\/busulfan\/low-dose total body irradiation\/granulocyte colony-stimulating factor-combined cytarabine in single cord blood transplantation for elderly patients with nonremission myeloid malignancies. Biol Blood Marrow Transplant. 2019;25:764-770.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s12185-020-02854-5","article-title":"Clinical outcomes of persistent colonization with multidrug-resistant Gram-negative rods in adult patients undergoing single cord blood transplantation","volume":"111","author":"Mizusawa","year":"2020","unstructured":"22. Mizusawa M, Konuma T, Kato S, Isobe M, Shibata H, Suzuki M, Takahashi O, Oiwa-Monna M, Takahashi S, Tojo A. Clinical outcomes of persistent colonization with multidrug-resistant Gram-negative rods in adult patients undergoing single cord blood transplantation. Int J Hematol. 2020;111:858-868.","journal-title":"Int J Hematol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.bbmt.2018.05.006","article-title":"Platelet transfusion refractoriness in single-unit cord blood transplantation for adults: risk factors and clinical outcomes","volume":"24","author":"Tanoue","year":"2018","unstructured":"23. Tanoue S, Konuma T, Kato S, Oiwa-Monna M, Isobe M, Jimbo K, Takahashi S, Tojo A. Platelet transfusion refractoriness in single-unit cord blood transplantation for adults: risk factors and clinical outcomes. Biol Blood Marrow Transplant. 2018;24:1873-1880.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref23","unstructured":"24. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828."},{"key":"ref24","unstructured":"25. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T, Martin P, Matthews D, Petersdorf E, Radich J, Riddell S, Rovira D, Sanders J, Schuening F, Siadak M, Storb R, Witherspoon RP. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250-259."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","unstructured":"26. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014;123:3664-3671.","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","unstructured":"27. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48:452-458.","journal-title":"Bone Marrow Transplant"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","unstructured":"28. Sorror ML, Storb RF, Sandmaier BM, Maziarz RT, Pulsipher MA, Maris MB, Bhatia S, Ostronoff F, Deeg HJ, Syrjala KL, Estey E, Maloney DG, Appelbaum FR, Martin PJ, Storer BE. Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. J Clin Oncol. 2014;32:3249-3256.","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/bloodadvances.2019032268","article-title":"External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Shouval","year":"2019","unstructured":"29. Shouval R, Fein JA, Shouval A, Danylesko I, Shem-Tov N, Zlotnik M, Yerushalmi R, Shimoni A, Nagler A. External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation. Blood Adv. 2019;3:1881-1890.","journal-title":"Blood Adv"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/bmt.2012.193","article-title":"Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT","volume":"48","author":"Sato","year":"2013","unstructured":"30. Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura S, Kikuchi M, Okuda S, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone Marrow Transplant. 2013;48:698-702.","journal-title":"Bone Marrow Transplant"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/bjh.14454","article-title":"C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality","volume":"180","author":"Patel","year":"2018","unstructured":"31. Patel A, Szydlo RM, Auner HW, Kanfer EJ, MacDonald DH, Milojkovic D, Altaf S, Innes A, Gabriel I, Rahemtulla A, Chaidos A, Karadimitris A, Olavarria E, Apperley JF, Pavl\u016f J. C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality. Br J Haematol. 2018;180:889-892.","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1182\/blood-2010-01-263624","article-title":"Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase","volume":"115","author":"Pavl\u016f","year":"2010","unstructured":"32. Pavl\u016f J, Kew AK, Taylor-Roberts B, Auner HW, Marin D, Olavarria E, Kanfer EJ, MacDonald DH, Milojkovic D, Rahemtulla A, Rezvani K, Goldman JM, Apperley JF, Szydlo RM. Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase. Blood. 2010;115:4018-4020.","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.bbmt.2015.04.002","article-title":"Design and validation of an augmented hematopoietic cell transplantation-comorbidity index comprising pretransplant ferritin, albumin, and platelet count for prediction of outcomes after allogeneic transplantation","volume":"21","author":"Vaughn","year":"2015","unstructured":"33. Vaughn JE, Storer BE, Armand P, Raimondi R, Gibson C, Rambaldi A, Ciceri F, Oneto R, Bruno B, Martin PJ, Sandmaier BM, Storb R, Sorror ML. Design and validation of an augmented hematopoietic cell transplantation-comorbidity index comprising pretransplant ferritin, albumin, and platelet count for prediction of outcomes after allogeneic transplantation. Biol Blood Marrow Transplant. 2015;21:1418-1424.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.bbmt.2018.05.005","article-title":"Baseline renal function and albumin are powerful predictors for allogeneic transplantation-related mortality","volume":"24","author":"Shouval","year":"2018","unstructured":"34. Shouval R, de Jong CN, Fein J, Broers AEC, Danylesko I, Shimoni A, Reurs MR, Baars AE, van der Schaft N, Nagler A, Cornelissen JJ. Baseline renal function and albumin are powerful predictors for allogeneic transplantation-related mortality. Biol Blood Marrow Transplant. 2018;24:1685-1691.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41375-018-0185-y","article-title":"The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Fein","year":"2018","unstructured":"35. Fein JA, Shimoni A, Labopin M, Shem-Tov N, Yerushalmi R, Magen H, Furie N, Kopel E, Danylesko I, Nagler A, Shouval R. The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation. Leukemia. 2018;32:1787-1794.","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bbmt.2019.01.006","article-title":"The prognostic impact of pretransplantation inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation","volume":"25","author":"Miyashita","year":"2019","unstructured":"36. Miyashita E, Konuma T, Kataoka J, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Sato T, Takahashi S, Tojo A. The prognostic impact of pretransplantation inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation. Biol Blood Marrow Transplant. 2019;25:981-988.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/sj.bmt.1705276","article-title":"Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse","volume":"37","author":"Min","year":"2006","unstructured":"37. Min CK, Kim SY, Eom KS, Kim YJ, Kim HJ, Lee S, Kim DW, Lee JW, Min WS, Kim CC. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse. Bone Marrow Transplant. 2006;37:493-498.","journal-title":"Bone Marrow Transplant"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jamaoncol.2017.2714","article-title":"Development and validation of a novel acute myeloid leukemia-composite model to estimate risks of mortality","volume":"3","author":"Sorror","year":"2017","unstructured":"38. Sorror ML, Storer BE, Fathi AT, Gerds AT, Medeiros BC, Shami P, Brunner AM, Sekeres MA, Mukherjee S, Pe\u00f1a E, Elsawy M, Wardyn S, Whitten J, Moore R, Becker PS, McCune JS, Appelbaum FR, Estey EH. Development and validation of a novel acute myeloid leukemia-composite model to estimate risks of mortality. JAMA Oncol. 2017;3:1675-1682.","journal-title":"JAMA Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaoncol.2019.0902","article-title":"Revised acute myeloid leukemia composite model using the 2017 European LeukemiaNet Risk Classification","volume":"5","author":"Sorror","year":"2019","unstructured":"39. Sorror ML, Storer BE, Nyland J, Estey EH. Revised acute myeloid leukemia composite model using the 2017 European LeukemiaNet Risk Classification. JAMA Oncol. 2019;5:1062-1064.","journal-title":"JAMA Oncol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbmt.2015.12.027","article-title":"Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese populations","volume":"22","author":"Kanda","year":"2016","unstructured":"40. Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W. Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese populations. Biol Blood Marrow Transplant. 2016;22:744-751.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T14:25:37Z","timestamp":1756736737000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-48457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2025.0125","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}